Firalis Testing Laboratory is Accredited ISO 17025
Firalis SAS, a service provider company in Biomarker R&D, is pleased to announce the accreditation of its testing laboratory by the French Accreditation Committee COFRAC1. The laboratory is dedicated to the measurement of biomarkers in human and preclinical samples by various technologies.
This accreditation reflects the competence of Firalis in running assay validation and testing of samples. Furthermore, the quality management system of the laboratory meets the requirements of ISO 9001:2008, as declared by IAF2, ILAC3 and ISO4 via a joint declaration. Overall, customers rely on a laboratory audited by a third party for their bio-analytical needs.
Prof. Hüseyin FIRAT, CEO of Firalis SAS, commented the accreditation as a major milestone for the company and an expected outcome of a long-established commitment to quality standards. “We have to raise the bar continuously, in order to provide always a better quality biomarker services and to fulfill the regulatory expectations of both customers and health authorities.” he added.
Important note: The above-mentioned accreditation does not apply to the Firalis products or company production process.
Firalis SAS is a privately owned life sciences company, creating novel values via biomarker discovery, development and regulatory qualifications; to establish an internal portfolio of biomarker-based diagnostic methods and to provide customized biomarker solutions. Firalis is active in the field of drug safety, cardiovascular, inflammatory and autoimmune diseases. The company has been awarded with several national and international prizes for its innovative approaches.
|1:COFRAC||Comité Français d’Accréditation (French Accreditation Committee)|
|2:IAF||International Accreditation Forum|
|3:ILAC||International Laboratory Accreditation Cooperation|
|4:ISO||International Organization for Standardization|